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Sex is a major factor determining adipose tissue distribution and the subsequent adverse effects of
obesity-related disease including type 2 diabetes. The role of gender on juvenile obesity and the
accompanying metabolic and inflammatory responses is not well established. Using an ovine model of
juvenile onset obesity induced by reduced physical activity, we examined the effect of gender on
metabolic, circulatory, and related inflammatory and energy-sensing profiles of the major adipose
tissuedepots.Despitea similar increase in fatmasswithobesitybetweengenders,malesdemonstrated
a higher storage capacity of lipids within perirenal-abdominal adipocytes and exhibited raised insulin.
In contrast, obese females became hypercortisolemic, a response that was positively correlated with
central fat mass. Analysis of gene expression in perirenal-abdominal adipose tissue demonstrated the
stimulation of inflammatory markers in males, but not females, with obesity. Obese females displayed
increased expression of genes involved in the glucocorticoid axis and energy sensing in perirenal-
abdominal, but not omental, adipose tissue, indicating a depot-specific mechanism that may be pro-
tective from the adverse effects of metabolic dysfunction and inflammation. In conclusion, young
males are at a greater risk than females to the onset of comorbidities associated with juvenile-onset
obesity. These sex-specific differences in cortisol and adipose tissue could explain the earlier onset of
the metabolic-related diseases in males compared with females after obesity. (Endocrinology 154:
3622–3631, 2013)
Obesityandassociatedcomorbiditiesarenowthe leadingpreventable causes of mortality, and approximately 3
millionadultsdieannuallyasaresultofbeingoverweight (1).
Excess weight gain and obesity can be attributed to an in-
crease intheratioofcalorieconsumptiontoexpenditure,and
this balance may be reset by a combination of lifestyle and
environmental and genetic factors (2). The recent increased
prevalence of obesity implies that behavioral and socioeco-
nomic factors, ie, modern sedentary lifestyles and an inade-
quate diet, especially that associated with social deprivation
in Western societies, are involved to a greater extent than
genetic constitution (3). There is increasing evidence that
children and/or adolescents who become obese are highly
likely to remain so as adults (4). Furthermore, risk factors
associated with obesity depend not only on the age at obesity
onset but also on the amount of accumulated fat tissue and
its anatomical distribution. With central obesity, which is
more prevalent in males, fat tissue accumulates in the upper
body, ie, within intraabdominal and ectopic regions (5),
whereas in premenopausal females, increased sc fat is accu-
mulated in peripheral and lower-body areas, ie, within the
gluteal and femoral regions (5). This gender dimorphism in
fat distribution is well established, and females tend to have
more adipose tissue than males. Nevertheless, body mass
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index-matched males have nearly twice the amount of vis-
ceral adipose tissue than females (5). Reduced visceral adi-
posity inpremenopausal femaleshasbeen linkedtothe lower
prevalence of obesity-related metabolic conditions, such as
hypertension, diabetes, hyperlipidemia, and cardiovascular
diseases, than those seen in body mass index-matched males,
although the incidences converge after the menopause with
those of males (6).
Adipose tissue secretes a range of adipokines, which
play important local and systemic roles in metabolism,
immunity, reproduction, and the cardiovascular system
(7). In obesity, adipocytes undergo hypertrophy and hy-
perplasia, resulting in increased production and secretion
of adipokines, which induce macrophage recruitment and
infiltration (8). This results in a cumulative state of inflam-
matory molecule production with additional macrophage
recruitment and activation, a mechanism proposed to con-
tribute to the chronic low-grade inflammation associated
with obesity (9). Additionally, central obesity promotes ac-
tivity of the hypothalamic-pituitary-adrenal (HPA) axis, in-
dicating thatobesity isa formofsystemicstress (10)whenthe
relationship between adipokine signaling hormones such as
leptinandadiponectin, togetherwithglucocorticoidsandthe
HPA axis, become dysregulated (10–13). Glucocorticoid
status isonecontributory factor in thepathologies surround-
ing obesity, and plasma cortisol has been reported to be
raised in females compared with males (14), although the
extent to which this may contribute to sex-specific responses
remains to be established.
We have previously shown an amplified inflammatory
profile within perirenal-abdominal adipose tissue and ad-
verse cardiovascular function in a sheep model of juvenile
onset obesity, mediated by a combination of increased
food intake and reduced physical activity commencing
from the time of weaning (15). Using a more modest model
of juvenile obesity in which only physical activity was re-
stricted, we have established that there is a pronounced
difference between genders in adverse effects on the renal
inflammatory response (14). The extent to which the ad-
ipose tissue response to obesity onset in early life differs
between depots is not known. We therefore compared the
effect of gender and obesity between the 2 major fat depots
in the sheep, ie, omental and perirenal-abdominal depots.
We wanted to investigate the hypothesis that the devel-
opment of juvenile-onset obesity promotes metabolic dys-
function and an amplified inflammatory state, mediated
by sex and adipose depot-specific adaptations.
Materials and Methods
Animal model
Animal experimentation was conducted in accordance with
the UK Home Office and the UK Animals (Scientific Procedures)
Act (1986). All animal work complied with the Principles of
Laboratory Animal Care (National Institutes of Health publi-
cation number 85–23, revised 1985) and approved by a local
research ethics committee at the University of Nottingham. As
previously published (14), immediately after weaning at 3
months, nonidentical twin sheep born to Blue-faced Swaledale
mothers (except for 2 sets of male-male twins) were separated
and randomly allocated into different physical activity groups,
ie, rearing in either a restricted obesogenic barn environment
with a stocking rate of 6 sheep per 19 m2 or in an unrestricted lean
pasture environment with a stocking rate of 6 sheep per 1125 m2.
Thechoiceofusingamild inductionofobesitywasmotivatedby
the hypothesis that a supraphysiological induction of obesity could
mask the gender specificity of early-onset responses (14). This ex-
perimental protocol resulted in lean females (n  7), obese females
(n  9), lean males (n  11) and obese males (n  9). All animals
at each stage were fed to fully meet their metabolic requirements
(16) with a mix of hay and concentrated pellets (Manor Farm
Feeds). At 17 months of age, between July and August when all
females were anestrous, each sheep was surgically implanted with
temporary jugular vein catheters and an iv glucose tolerance test
(GTT) undertaken, 12 hours after food withdrawal, with 5-mL
blood samples withdrawn into EDTA tubes at 10-, 5-, 0-, 10-,
20-, 30-, 60-, 90-, and 120-minute time points after 0.5 g/kg1
glucose perfusion, to enable calculation of area under the curve
(AUC) (17). A normal feeding regimen was restored after the GTT
had been performed and, 5-mL blood samples were withdrawn
from overnight fasted animals into lithium heparin tubes for use in
determination of plasma leptin and cortisol levels at 0-, 2-, 4-, 8-,
and 24-hour time points after being fed to metabolic requirements.
Blood samples were centrifuged at 2500  g for 10 minutes at 4°C
to obtain plasma, which was stored at 80°C until analysis. Ani-
mals were humanely euthanized: all adipose depots were weighed,
frozen in liquid nitrogen, and stored at 80°C, whereas represen-
tative samples of the perirenal-abdominal depot were partially dis-
sected and fixed in 10% formalin for histological processing.
Laboratory analyses
Adipocyte histology
Sections (5 m) were sledge microtomed (Anglia Scientific) at
random from perirenal-abdominal adipose tissue samples,
mounted on Superfrost Plus slides (Menzel-Gläser Inc), and
stained using hematoxylin and eosin. Sections were visualized
through a Leica digital resolution microscope (Leica Microsys-
tems) at 20 magnification and photographed for analysis
(Hamamatsu digital camera). Adipocyte perimeters and areas
were measured for all complete adipocytes in the field of vision,
using one slide for lean (40 cells per animal) and two slides
for obese sheep (20 cells per animal). Individual adipocyte
perimeters (micrometers) and areas (square micrometers)
were determined using Volocity version 5.2.0 image software
(PerkinElmer).
Gene expression analysis
Each adipose tissue sample (1.0 g) was treated with 1 mL
TRI reagent (Sigma-Aldrich), and total RNA was extracted with
an RNeasy Plus Mini extraction kit (QIAGEN) using an adapted
version of the single-step acidified phenol-chloroform homogeni-
zation method (18). Sample integrity was confirmed by Nanodrop
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ND-1000 spectroscopy (Nanodrop Technologies). RNA samples
were normalized by dilution to 1 ng/L, reverse transcribed using
a Superscript II reverse transcriptase enzyme kit (Invitrogen Ltd),
and cDNA was amplified on a Touchgene Gradient thermocycler
(Techne Inc).
Quantitative PCR was performed using SYBR Green Taq poly-
merase master mix (Thermo Scientific) with ovine-specific oligo-
nucleotide primers against a cDNA gene standard curve to verify
the efficiency of the reaction and with appropriate negative con-
trols. The mRNA abundance for the following genes was deter-
mined: 11-hydroxysteroid dehydrogenase type 1 (11BHSD1)
forward,GGCCAGATCCCTGTCGAT,reverse,AGCGGGATAC
CTTCTTT; 11-hydroxysteroid dehydrogenase type 2
(11BHSD2) (19); adiponectin forward, ATCAAAGTCTGGAA
CCTCCTATCTAC, reverse, TTGCATTGCAGGC TCAAG; adi-
ponectin receptor forward, GGCAAGTGTGACATCTGGTTTC,
reverse, GAAACGGAACTCCTGGAGGTT; glucocorticoid re-
ceptor type 2 (GR) (20); IL-6 (IL6) (21); leptin forward, GGGT
CACTGGTTTGGGACTTCA, reverse, ACTGGCGAGGATCT
GTTGGTA; leptin receptor forward, TGAAACCACTGCCTCC
ATCC, reverse, TCCACTTAAACCATAGCGAATC, AMP-
related kinase (AMPK) (22); Bcl-2-associated X protein (BAX);
mammalian target of rapamycin (mTOR); monocyte chemoattrac-
tant protein 1 (MCP1) (23); and toll-like receptor 4 (TLR4) (21).
Gene expression was determined using GeNorm normalization
against multiple reference genes L19 ribosomal protein 19
(RPL19) (24) and large ribosomal protein (RPO) (25), using
GeNorm software version 3.5 (Primer Design Ltd).
Plasma metabolite and hormone analysis
Plasma glucose [inter- and intraassay coefficient of variation
(CVs) of 3.5% and 2.3%], nonesterified fatty acid (inter- and
intraassay CVs of 3.8% and 1.8%), and triglyceride (inter- and
intraassay CVs of 4.2% and 2.9%) concentrations were deter-
mined colormetrically, insulin (inter- and intraassay CVs of
5.4% and 4.4%) and cortisol (inter- and
intraassay CVs of 4.6% and 3.5%) by
ELISA for which the limits of detection
were 0.15 ng/mL and 6.9 nM, respectively
(17) and plasma leptin (inter- and intraas-
sayCVsof7.4%and4.9%)byRIA,which
was specific for ovine leptin, and the limit
of detection was 0.8 ng/mL (26).
Statistical analysis
For consistency, all data are expressed
as mean  SEM. Data were subjected to
the Kolmogorov-Smirnov test to deter-
mine their distribution followed by either
ANOVA or Kruskal-Wallis statistical
tests, respectively, for parametric and non-
parametric data, with applied multiple
testing post hoc corrections. Exceptions to
this were the adipocyte population fre-
quencies, which were treated with an F test
for variance distribution (see Figure 3);
time course analyses (see Figure 4), which
were treated with a 2-way ANOVA with
repeated measures; and correlations,
which were treated with linear regression
Figure 1. Mean perirenal-abdominal adipocyte perimeter (A) and area (B), for lean (L), obese (O)
female (F) and male (M) sheep. Values are mean  SEM. ***, P  .001. C, Positive linear
relationship between perirenal-abdominal adipose tissue (PAT) mass and adipocyte area
(r2  0.85; P  .0001) in lean (open circles) and obese females (open squares) and lean (filled
circles) and obese males (filled squares).
Table 1. Food Intake and Whole-Body, Lean, Perirenal-Abdominal, and Omental Fat Mass of Lean and Obese
Young Adult Sheep
Lean Female
(n  7)
Obese Female
(n  9)
Lean Male
(n  11)
Obese Male
(n  9)
Effect of Gender
Within Body
Weight Group
Relative energy intake,
MJ/kg1 per 24 h1
0.35  0.02 0.38  0.02 0.29  0.02 0.36  0.02 NS
Body weight, kg 49.50  1.04 61.56  2.07a 56.38  2.59 83.84  1.82a P  .005
Lean mass, kg 39.72  0.87 44.03  1.22 49.09  1.89 62.41  1.30 P  .005
Relative fat mass, % 8.42  1.12 14.31  1.26a 6.77  0.66 12.93  1.06a NS
Perirenal-abdominal fat, kg 0.31  0.04 1.06  0.13b 0.22  0.02 0.96  0.11a NS
Omental fat, kg 0.33  0.06 1.62  0.17c 0.26  0.05 1.54  0.16b NS
Abbreviations: NS, no significant difference. Values are mean  SEM.
a
P  .005, effect of obesity within gender group.
b
P  .001, effect of obesity within gender group.
c
P  .05, effect of obesity within gender group.
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analysis and Pearson’s correlation coefficient (see Figure 5). These
analyses were performed using PASW version 17.12 statistics soft-
ware (IBM UK). Statistical significance was accepted with a confi-
dence interval of 95% (P  .05).
Results
The effects of sex and juvenile obesity on fat mass
and adipose tissue composition
As previously published (14), total body and lean tissues
weights were increased by the obesogenic environment, and
the increase in both omental and perirenal-abdominal fat
mass was similar in both genders, whereas the food intake
(per kilogram of body weight) was similar between groups
(Table 1). In perirenal-abdominal adipose tissue, this was
accompanied by an increase in adipocyte perimeter and area
irrespective of sex (Figure 1 and Supplemental Figure 1, pub-
lishedonTheEndocrineSociety’s JournalsOnlinewebsiteat
http:// endo.endojournals.org), with the depot sizebeingpos-
itively correlated with adipocyte area. Lean males had more
small adipocytes than females, a differ-
ence that disappeared with adipocyte
enlargement after obesity (Figure 2).
The effect of increased
adiposity on basal and
stimulated plasma hormone and
metabolite concentrations
Fasting insulin increased with
obesity in males but not females (Ta-
ble 2), whereas AUC after the GTT
was increased in both genders (Fig-
ure 3A). Plasma leptin prior to feed-
ing was unaffected by gender (Table
2), whereas its response to feeding
was greater in obese animals (Figure 3B). In contrast, prior
to feeding, plasma cortisol was higher in females than
males, although this difference was statistically significant
only in obese animals (Table 2). The raised plasma cortisol
in obese females was maintained throughout the 24-hour
sampling period (Figure 3C). There were no significant
differences in plasma glucose, nonesterified fatty acids
(NEFAs), or triglycerides with obesity or between genders
(Table 2). For all animals, the total fat mass was positively
correlated with leptin response to feeding, whereas vis-
ceral fat mass was positively correlated with cortisol in
females only (Figure 4).
Effect of gender and obesity on genes
regulating metabolic, inflammatory, apoptotic, and
energy-sensing pathways and glucocorticoid action
In perirenal-abdominal fat, gene expression for adi-
ponectin was higher in obese males than females, whereas
the abundance of transcripts for its receptor, together with
Figure 2. Frequency distribution (percentage) of perirenal-abdominal adipocyte area for lean
and obese female (grey bars) and lean male and obese male (black bars) sheep. Variance of
distribution between lean groups by F test showed significance (P  .0002). Between obese
groups there was no statistical significance.
Table 2. Endocrine and Metabolic Responses Under Fasting and Stimulated Conditions in Lean and Obese Young
Adult Sheep
Lean Female
(n  7)
Obese Female
(n  9)
Lean Male
(n  11)
Obese Male
(n  9)
Effect of Gender
Within Body
Weight Group
Fasting plasma insulin, ng/mL 0.09  0.01 0.12  0.01 0.09  0.01 0.14  0.02a NS
Insulin AUC, ng/mL 15.2  3.7 48.9  13.8 30.6  13.4 71.5  7.3a NS
Fasting plasma leptin, ng/mL 2.61  0.45 3.95  0.44 2.97  0.17 4.35  0.52 NS
Leptin AUC, ng/mL 67  7 125  12b 63  4 130  16c NS
Fasting cortisol, nmol/L 31.7  6.3 54.6  9.7 19.2  9.7 22.6  4.2 P  .005
Cortisol AUC, nmol/L 579  114 1326  252b 377  48 504  58 P  .005
Fasting glucose, mmol/L 3.04  0.18 3.08  0.14 2.94  0.10 3.03  0.11 NS
Fasting NEFAs, mmol/L 0.43  0.06 0.49  0.06 0.40  0.03 0.50  0.06 NS
Fasting triglycerides, mmol/L 0.35  0.06 0.31  0.03 0.40  0.05 0.38  0.07 NS
Abbreviation: NEFA, nonesterified fatty acid; NS, no significant difference. Values are mean  SEM.
a
P  .05, effect of obesity within gender group.
b
P  .005, effect of obesity within gender group.
c
P  .001, effect of obesity within gender group.
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those of leptin and its receptor, was unaffected by obesity
and gender (Table 3). For omental fat, however, the
mRNA abundance for leptin was greater in females than
males, a difference that was amplified with obesity
[female: lean, 0.07  0.01; obese, 0.48  0.01 (P  .001);
male: lean, 0.05  0.01; obese, 0.24  0.04 arbitrary units
(a.u.) (male vs female, P  .05)]. In contrast, in omental
fat, gene expression for adiponectin was raised with obe-
sity but unaffected by gender [female: lean, 0.21  0.03;
obese, 0.34  0.03 (P  .05); male: lean, 0.21  0.04;
obese, 0.34  0.04 a.u. (lean vs obese P  .05)], but
mRNA for leptin and adiponectin receptors and IL6 was
below the limits of detection in this depot. When mRNA
markers of inflammation within perirenal-abdominal ad-
ipose tissue were considered, each gene measured was
highly abundant. Furthermore, IL6 gene expression was
greater in lean but not obese males compared with females
(Table 3). In contrast, mRNA abundance for both TLR4
and MCP1 were raised with obesity
in males but not females in perirenal-
abdominal but not omental fat (eg,
TLR4: female, lean 0.31  0.05;
obese, 0.42  0.04; male: lean,
0.31  0.02; obese, 0.39 
0.06 a.u.).
The mRNA abundance for the
GR was similar between genders, ir-
respective of body weight, in both fat
depots examined, although it was
raised with obesity in the perirenal-
abdominal depot in females (Table
3), and in the omental depot in males
[female: lean 0.39  0.05; obese
0.51  0.03; male: lean 0.37  0.04;
obese 0.55  0.08 a.u. (P  .05)]. In
contrast, 11HSD1 mRNA abun-
dance was similar between all groups
in the omental depot (female: lean
0.46  0.08; obese 0.35  0.03;
male: lean 0.40  0.08; obese 0.36 
0.04 a.u.) but in the perirenal-ab-
dominal depot was lower in obese
males than females (Table 3). Gene
expression for 11HSD2 was below
the limits of detection in the omental
fat, but in the perirenal-abdominal,
the depot was higher in lean males
than females (Table 3).
There were marked differences
between genders and fat depots in
the genes involved in apoptosis
(BAX) and energy sensing (AMPK
and mTOR) (Table 4). In perirenal-abdominal fat, the
expression of each of these genes was greater only in obese
females than lean females, whereas in omental fat, an ef-
fect of obesity was found in the males but not females.
Discussion
A major finding from our study is that although obesity
promoted comparable increases in total fat mass and adi-
pocyte size in both sexes, females alone were characterized
as showing a pronounced increase in plasma cortisol with
obesity. Raised cortisol is an established measure of phys-
iological stress (27), suggesting that the higher plasma cor-
tisol previously reported in adolescent females (28) reap-
pears with obesity. This could therefore represent an
adaptive response that protects females from the early on-
set of the adverse effects from obesity (14). Similarly, the
Figure 3. Time course of changes in plasma insulin during a GTT (A), plasma leptin (B), and
cortisol (C) in response to feeding in lean (open circles) and obese female (filled circles) and lean
(open squares) and obese male (filled squares) sheep. Dotted line represents glucose infusion
time or feeding time point. Values are mean  SEM with significant differences between lean
and obese animals of the same gender indicated. *, P  .05; **, P  .005; ***, P  .001.
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impaired insulin response to a glucose challenge found in
obese males could be related to their failure to increase
plasma cortisol with obesity, ultimately placing them at
increased risk of diabetes.
Overall, in accord with epidemiological evidence (29),
only obese males had elevated plasma insulin, indicating
their increased sensitivity to developing insulin resistance.
These gender differences in insulin responsiveness have been
attributed to sex hormones because, in humans, they disap-
pear after the menopause when estrogen declines at the ex-
pense of androgens. This hormonal shift is suspected to be a
major determinant behind the subsequent rise in visceral fat
mass in females, which can lead to in-
sulin resistance (30). The exact mech-
anism behind a sex hormone-medi-
ated retardation in the rate of
development of insulin resistance in
obesity observed in females is cur-
rently unknown but could potentially
include a change in cortisol action.
Theeffectofgender inresponsetoobe-
sity on HPA axis activation and the
resulting stress response are likely to
be due, in part, to differences in the
circulating gonadal sex steroid hor-
monemilieu.Estrogen,acting through
the central nervous system, can am-
plify HPA function, whereas T has the
oppositeeffect (31). It ispossiblethere-
fore that juvenile-onset obesity pro-
motes estrogenic effects on the HPA
axis in females. This results in raised
cortisol, an outcome not observed in
the obese males, which conversely may be due to suppressive
effects of T (32).
Changes in adipose tissue deposition and
physiology
We have shown that both sexes exhibit an increase in
total fat mass after early life exposure to an obesogenic
environment. As expected, lean and obese female animals
were fatter than the males, results that are consistent be-
tween species including humans (33). In obese humans,
total fat mass is greater than 32% and greater than 25%
Table 3. Effect of Gender and Juvenile Obesity on Gene Expression Markers of Adipose Tissue Metabolism,
Inflammation, and Glucocorticoid Action in Perirenal-Abdominal Adipose Tissue of Young Adult Sheep
Pathway Gene
Accession
Number
Lean
Female
(n  7)
Obese
Female
(n  9)
Lean
male
(n  11)
Obese
Male
(n  9)
Effect of Gender
Within Body
Weight Group
Adipose tissue metabolism
Leptin NM_173928.2 0.14  0.06 0.27  0.06 0.18  0.10 0.25  0.04 NS
Leptin receptor NM_001009763.1 0.22  0.02 0.27  0.06 0.24  0.07 0.18  0.05 NS
Adiponectin XM_004003053 0.10  0.02 0.09  0.03 0.24  0.14 0.46  0.09 P  .05
Adiponectin receptor XM_004007604 0.27  0.05 0.50  0.07 0.41  0.05 0.36  0.06 NS
Inflammation
IL6 NM_001009392 0.19  0.02 0.34  0.10 0.35  0.05 0.36  0.07 P  .05
MCP1 NM_174006 0.08  0.02 0.24  0.10 0.06  0.01 0.26  0.10a NS
TLR4 NM_001135930.1 0.32  0.03 0.41  0.04 0.22  0.02 0.35  0.04a NS
Glucocorticoid action
11BHSD1 NM_001009395.1 0.16  0.04 0.14  0.02 0.10  0.02 0.07  0.01 P  .05
11BHSD2 NM_174642.2 0.29  0.03 0.43  0.03 0.53  0.08 0.70  0.20 P  .05
GR NM_001114186.1 0.38  0.03 0.55  0.06a 0.31  0.03 0.39  0.03 NS
Abbreviations: GR, glucocorticoid receptor (type 2); 11BHSD1, 11B hydroxysteroid dehydrogenase type 1; 11BHSD2, 11B hydroxysteroid
dehydrogenase type 2; IL6, IL-6; MCP1, monocyte chemoattractant protein 1; NS, no significant difference;TLR4, Toll-like receptor 4. Values are
mean  SEM.
a
P  .05, effect of obesity within gender group.
Figure 4. Positive linear relationship between total fat mass and plasma leptin AUC response to
feeding in lean and obese females (r2  0.58; P  .0006) and lean and obese males (r2  0.68;
P  .0001) (A) and total visceral fat mass and plasma cortisol AUC response to feeding in female
(r2  0.63; P  .001) (B) but not in male sheep (r2  0.07; not significant). Analyzed groups
represented by lean (open circles) and obese females (filled circles) and lean (open squares) and
obese males (filled squares).
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of body weight for females and males, respectively (34).
Yet in the present study, despite the 2-fold increase of total
body fat including central depots, obese females had ap-
proximately 15% and males had approximately 13% to-
tal fat mass. We therefore suggest that our study’s model
of juvenile-onset obesity, which is mediated only through
restricted physical activity, resulted in a moderate obesity,
which was still sufficient to cause significant changes in
adiposity and metabolic homeostasis.
The 3-fold enlargement in perirenal adipocytes with
obesity, irrespective of gender, indicates that depot en-
largement was a consequence of adipocyte hypertrophy
rather than hyperplasia, a finding also observed in humans
(35). Population distribution analysis identified that lean
males had smaller perirenal adipocytes than females, but
after exposure to an obesogenic environment, this differ-
ence was removed. These results reflect gender differences
in responsivenessof visceral adipocytes,withmaleshaving
a larger storage capacity for triglycerides and lipids, po-
tentially encouraging increased central deposition with
early-onset obesity. In adult humans, sc adipocytes are
larger and have increased triglyceride storage compared
with intraabdominal adipocytes, and in females, adi-
pocytes from this depot are more active, playing a greater
role in the metabolic profile (36).
Differences in gender response to obesity in
metabolic and inflammatory pathways between
central fat depots
The adaptive response to raised cortisol in females did
not appear to extend to adipose tissue because there were
only modest differences in gene expression responsiveness
between genders and the magnitude of overall response to
obesity was similar. In human obesity, hypercortisolism is
a prominent feature, both systemically and intracellularly
(37), when cortisol production and clearance are simul-
taneously elevated, but plasma concentrations are unaf-
fected (38). A positive relationship between elevated cor-
tisol clearance and increased fat mass is present in females
(39), suggesting their adipose tissue has a greater capacity
to bind cortisol acting through its receptor. This divergent
sensitivity between sexes is supported by the gender-spe-
cific relationship we observed between central fat mass
and plasma cortisol response to feeding.
Adult onset obesity also affects glucocorticoid metab-
olism with raised gene expression for both GR and
11BHSD1, which is greater in visceral compared with sc
adipose tissue (40) when increased plasma cortisol is pos-
itively correlated to visceral obesity (40). Surprisingly, in
our study, gene expression for 11BHSD1 was reduced
with obesity in perirenal-abdominal, but not omental, fat,
and this would be predicted to reduce local cortisol syn-
thesis (42). Chronic exposure to elevated cortisol and con-
comitant activation of the HPA axis can contribute to the
pathogenesis and development of abdominal obesity (43).
Despite a divergent relationship between genders found in
the present study, the increase in fat mass with obesity was
similar as were the metabolic consequences in terms of
changes in plasma leptin. Raised plasma and tissue cortisol
can, however, suppress inflammation via inhibition of im-
mune cell function (44) and, as a consequence, can be
protective against the chronic low-grade inflammation
that accompanies obesity (45) as we have previously found
in the kidneys of obese females (14).
Table 4. Contrasting Effect of Gender and Juvenile Obesity on Gene Expression for Markers of Apoptosis and
Energy Sensing Between Perirenal-Abdominal and Omental Adipose Tissue of Young Adult Sheep
Pathway Gene
Accession
Number
Lean Female
(n  7)
Obese Female
(n  9)
Lean Male
(n  11)
Obese Male
(n  9)
Effect of Gender
Within Body
Weight Group
Perirenal-abdominal depot
Apoptosis
BAX XM_004015364.1 0.35  0.03 0.56  0.06b 0.41  0.05 0.57  0.06 NS
Energy sensing
AMPK NM_001112816 0.25  0.02 0.55  0.08a 0.23  0.02 0.33  0.04 P  .05
mTOR NM_001145455 0.37  0.03 0.57  0.06a 0.43  0.03 0.52  0.04 NS
Omental depot
Apoptosis
BAX XM_004015364.1 0.23  0.05 0.33  0.07 0.36  0.07 0.78  0.07a P  .05
Energy sensing
AMPK NM_001112816 0.26  0.05 0.55  0.07b 0.23  0.02 0.41  0.03b NS
mTOR NM_001145455 0.28  0.09 0.44  0.08 0.41  0.07 0.80  0.17b NS
Abbreviations: AMPK, AMP-related kinase; BAX, Bcl-2-associated X protein; mTOR, mammalian target of rapamycin; NS, no significant difference.
Values are mean  SEM.
a
P  .01, effect of obesity within gender group.
b
P  .05, effect of obesity within gender group.
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Although fat mass is a primary determinant of plasma
leptin across species (46), positive correlations between
hyperleptinemia, hyperlipidemia, insulin resistance, and
hypertension have been shown to be independent of total
adiposity (47). We saw no relationship between plasma
leptin and insulin but a positive correlation between total
fat mass and plasma leptin, irrespective of gender. It is
possible that a combination of early-onset obesity, to-
gether with the relatively moderate nature of the obeso-
genic challenge, contributed to raised plasma leptin in an
attempt to control appetite and energy balance and thus
further weight gain. Furthermore, leptin gene transcrip-
tion and protein synthesis are both affected by gross
changes in energy intake (48), although this response can
be adipose depot and gender specific (49), with an en-
hanced leptin mRNA response in sc, compared with vis-
ceral adipose tissue (50). In accord with this proposal, we
found raised leptin gene expression only in omental, but
not perirenal-abdominal, adipose tissue with obesity, and
this response was greater in females than males. However,
in perirenal-abdominal, but not omental, adipose tissue,
gene expression for both MCP1 and TLR4 were raised
with obesity in males but not females. This is also indic-
ative of an enhanced inflammatory related response (51),
which may contribute to insulin resistance (52, 53).
Interestingly, although 11BHSD2 mRNA was undetect-
able in omental fat, the increased perirenal-abdominal fat
mass with age was negatively correlated with 11BHSD2
gene expression, and this could reflect an increase in the size
of thisdepotduring juvenile life (54). In thepresent study,we
foundhighergeneexpression in leanmales than femaleswith
no effect of obesity. One explanation for the different re-
sponsiveness between omental and perirenal-abdominal fat
depots could reside in their divergent developmental origins,
with the perirenal-abdominal depot being the largest in the
fetal sheep (55) in which it is primarily characterized as being
brown (56). Then during postnatal life, it transforms into a
whiteorbeigedepot,whereas, inmarkedcontrast, theomen-
tal fat depot does not appear until after birth and is purely a
white fat depot (57). The extent to which these divergent
developmental profiles could contribute to gender-specific
changes in glucocorticoid action remains to be established.
Intracellular glucocorticoid binding to the GR is a path-
way involved in the inhibition of cytokine transcription
and production (58), and the increase in both cortisol and
GR within perirenal-abdominal adipose tissue could have
acted together to prevent any change in the expression of
inflammatory genes with obesity in females. In accord
with this proposal, gene markers for both apoptosis and
energy sensing were raised with obesity only in females
within their perirenal-abdominal, but not omental, de-
pots. For males, however, the opposite response was seen,
and this may, potentially, reflect differences in epigenetic
regulation (41). The extent to which the changes we have
observed for gene expression are translated directly into
protein remains to be established, although it is well rec-
ognized that undertaking this type of analysis on ovine
tissues remains a challenge due to the scarcity of reliable
and fully validated antibodies (56).
In conclusion, sex has a major influence on both the
endocrine and adipocyte responses to juvenile-onset obe-
sity. Consequently, males show a more pronounced re-
sponse than females, resulting in amplified inflammatory
gene expression, which is predicted to place them at
greater risk of subsequent metabolic dysfunction. Fe-
males appear to be protected from such a response as a
consequence of raised cortisol and greater adipocyte
sensitivity in a depot-specific manner. These findings
further explain the dimorphic gender response to obe-
sity and its comorbidities.
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